“…A number of codling moth insecticides classified as reduced‐risk or OP alternatives have been registered in Spain since the 1980s and are recommended by IPM programs: the insect growth regulator fenoxycarb, the neonicotinoid thiacloprid, the ecdysone receptor agonists methoxyfenozide and tebufenozide, the voltage‐dependent sodium channel blocker indoxacarb, the nicotinic acetylcholine receptor allosteric modulator spinosad and, recently, the ryanodine receptor modulator chlorantraniliprole. Codling moth cross‐resistance among some of these reduced‐risk insecticides groups and OPs and pyrethroids have been detected in some European countries, the USA and Canada, even with pesticides that have been registered recently or have not yet been registered . No codling moth susceptibility study has been reported investigating these new chemical insecticides, with the exception of thiacloprid, which has been tested in Spanish field populations, with studies showing generally high levels of enzymatic detoxification, attributable mainly to cytochrome P450 polysubstrate monooxygenases (PSMOs) (in neonate larvae, adults and post‐diapausing larvae), but also to glutatione S‐transferases (GSTs) (in adults and post‐diapausing larvae) and esterases (ESTs) (in post‐diapausing larvae) …”